NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc., and EXINI ...
Nine-year follow-up for a study of diffusion-weighted MRI in a prospective active surveillance cohort for prostate cancer. This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This ...
A biopsy is the only test that can confirm a cancer diagnosis. However, before doctors conduct a biopsy, they may take a person’s medical history, perform a physical exam, and order various imaging ...
Figure 1. A 74-y-old man at initial staging with PSMA PET that demonstrates low uptake in primary tumor (A, arrowhead) and left pelvic side wall node (A, arrow). Bone scan was read as positive by 2 of ...
Cone-beam CT (CBCT) is considered the gold standard for imaging peri-implant bone, but researchers wondered if another modality without the radiation dose might be more accurate. They tested CBCT ...
Use of computed tomography and bone scans in low-risk prostate cancer cases has been in decline, but doctors continue to order these imaging modalities despite professional guidelines that do not ...
Share on Pinterest A study of bone scans is helping scientists determine the prevalence of cardiac amyloidosis. Ben Hasty/MediaNews Group/Reading Eagle via Getty Images Cardiac amyloidosis (CA) causes ...
Circulating Tumor DNA Dynamics Fail to Predict Efficacy of Poly(ADP-ribose) Polymerase/VEGFR Inhibition in Patients With Heavily Pretreated Advanced Solid Tumors Patients with bone metastatic CRPC ...
An automated bone scan algorithm has shown its value in determining the response to radium-223 (Ra-223) treatment for patients with metastatic castration-resistant prostate cancer (mCRPC), according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results